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حالة ورم خبيث متكرر للنسيج الليفي اجللدي الناتئ مع تصبغ ومتايز عضلي
�شوريكا ياداڤ، نيدي ڤريما، نيتا كورانا، �شو�شانت نيوجي
abstract: Dermatofibrosarcomas protuberans (DFSP) are rare low-grade tumours with various subtypes and 
usually occur among middle-aged adults. However, myoid differentiation is very rare. We report a 44-year-old 
woman who presented to the Lok Nayak Jai Prakash Hospital, New Delhi, India, in 2017 with a recurrent pigmented 
DFSP presenting as an arm swelling. Upon histological and immunohistochemical analysis, myoid differentiation 
was confirmed. A literature review of the clinical and histopathological features of this rare entity is presented.
Keywords: Dermatofibrosarcoma Protuberans; Melanocytes; Pigmentation; Cell Differentiation; Case Report; 
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امللخ�ص: تعترب الأورام اخلبيثة للن�شيج الليفي اجللدي الناتئ من الأورام النادرة ذات ال�رضا�شة املنخف�شة ولها اأنواع عدة، وحتدث غالبًا 
عند البالغني يف منت�شف العمر، اإل اأن حدوث متايز خلاليا الورم اإىل النوع الع�شلي يعترب نادر احلدوث، ن�شجل هنا حالة ملري�شة يف العقد 
الرابع من العمر عوينت يف م�شت�شفى لوك ناياك جاي بركا�ض يف منطقة نيودلهي يف عام 2017، وكانت م�شابة بورم متكرر يف الذراع 
من نوع الن�شيج الليفي اجللدي اخلبيث الناتئ وامل�شاحب بالت�شبغ، واأظهرت التحاليل املجهرية وفحو�ض الأن�شجة با�شتخدام الكيميائية 
املناعية وجود متايز للخاليا اإىل اأن�شجة ع�شلية داخل الورم، كما يتم عر�ض املن�شورات ال�شابقة عن اخلوا�ض ال�رضيرية واملجهرية ملثل 
هذه احلالة النادرة احلدوث.
الكلمات املفتاحية: ورم الن�شيج الليفي اجللدي اخلبيث الناتئ؛ اخلاليا ال�شبغية؛ الت�شبغ، متايز اخلاليا؛ تقرير حالة؛ الهند.
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Dermatofibrosarcomas protuberans (DFSP) are rare low-grade sarcomas involv-ing the dermis and subcutaneous tissue.1,2 
This type of tumour has a low rate of distant metastasis, 
but a higher rate of local recurrence. Histological sub- 
types of DFSP include giant-cell, pigmented, sclerosing, 
atrophic, myoid and fibrosarcomatous types.1,2 Of these, 
pigmented DFSP are characterised by interspersed 
melanin-rich dendritic cells and are very rare, account- 
ing for less than 5% of all reported cases of DFSP.1 
However, the origin of myoid differentiation in DFSP 
and its clinical significance is unknown. This case 
report describes a case of myoid differentiation in 
recurrent pigmented DFSP presenting as an arm 
swelling in an adult female patient.
Case Report
A 44-year-old woman presented to the Lok Nayak Jai 
Prakash Hospital, New Delhi, India, in 2017 with a 
recurrent mass on her right upper arm. The tumour 
had regrown since being surgically removed three years 
prior, at which time it had been histopathologically 
diagnosed as a DFSP. At presentation, the lesion was 
attached to the overlying skin, measuring 8 x 7 x 6 cm. 
A computed tomography (CT) scan showed a homo- 
geneously-enhancing soft tissue lesion in the subcut-
aneous plane of the lateral aspect of the middle-third 
of the right arm, measuring 7 x 6 x 4.5 cm [Figure 1A]. 
The lesion had well-defined margins except medially, 
where it was abutting the deltoid muscle with the loss 
of the intervening fat planes. However, CT scans of the 
chest, abdomen and head and neck region were normal. 
There was no evidence of organomegaly or lymphade-
nopathy. The patient subsequently underwent wide 
surgical excision of the lesion.
Upon gross examination, the excised soft tissue 
mass measured 13 x 11 x 5 cm. The surface of the lesion 
showed a firm homogenous polypoidal greyish-white 
growth of 6 x 6 x 4.5 cm, which extended deep into the 
underlying dermis [Figure 1B]. There were no areas of 
haemorrhage or necrosis. Histologically, the overlying 
skin was unremarkable. The tumour itself was located 
in the dermis and was composed of monomorphic 
spindle cells arranged in a storiform and fascicular 
pattern with a parallel arrangement of cells [Figure 2A]. 
In certain areas, the tumour was more cellular and 
composed of elongated cells with moderate cytoplasm 
and elongated-to-plump nuclei, which were mostly 
perivascular [Figure 2B]. The eosinophilic cells were 
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patient was symptom-free and there was no sign of 
disease recurrence. 
Discussion
In general, DFSP occur mostly in middle-aged adults, 
but have been reported in patients between 8–87 years 
old.3 Men are affected more often than women at a 
ratio of 2.3:1.4 This type of tumour is usually painless 
and presents as a long-standing solitary multinodular 
mass. Commonly affected sites include the trunk, 
particularly the back, and the limbs, chest and head 
and neck region.1,3 The tumour is locally aggressive and 
usually infiltrates the deep dermis and subcutaneous 
fat.3 A genetic study found that 89% of DFSP cases had 
collagen type I alpha 1 platelet-derived growth factor β 
fusion transcripts.4 A classical histological feature of 
DFSP is a storiform growth pattern of benign-looking 
spindle cells. Histopathologically, CD34 is considered 
a highly-specific marker of DFSP.5 
The origin of muscle differentiation in DFSP is 
debatable. Calonje et al. first described myoid differen- 
tiation in five cases of DFSP either with or without 
fibrosarcomatous components; because the myoid areas 
were distributed throughout the tumour, the authors 
concluded that these cells form their own areas.6 
O’Connell et al. studied two cases of fibrosarcoma 
arising in DFSP and came to a similar conclusion.7 Other 
researchers have claimed that myoid differentiation is 
solely a reactive phenomenon, with stromal myofibro-
blasts showing some degree of hyperplasia.8,9 Sanz- 
Trelles et al. concluded the myoid areas in DFSP to be 
the result of vascular smooth muscle cell hyperplasia 
or the proliferation of pericytes.10 Another study 
demonstrated a close relationship between blood 
vessels in the tumour and areas of myoid differ-
entiation.11 Ohtani et al. found smooth muscle actin- 
expressing myoid cells in a case of fibrosarco-
matous DFSP which had metastasised to the lung; 
the researchers suggested that myoid differentiation 
may therefore be neoplastic in origin.12 However, no 
relationship between the myoid areas and the blood 
vessels was found; furthermore, these areas differed in 
appearance from the pericytes.12
bland-looking without pleomorphism or mitotic fig- 
ures. The focal tumour cells contained brown intra-
cellular pigment [Figure 2C]. The tumour had infil-
trated the underlying soft tissue; however, all of the 
resected margins, including the circumferential resected 
margins and deep resection plane, were tumour-free. 
There was no evidence of mitosis, cellular atypia or 
necrosis.
An immunohistochemical panel of the tumour 
cells showed diffuse expression of vimentin and cluster 
of differentiation (CD)34 [Figure 3A]. The cells with 
eosinophilic cytoplasm showed immunohistochemical 
expression of smooth muscle actin, indicative of myoid 
differentiation [Figure 3B]. These areas were negative 
for CD34 [Figure 3C]. The final diagnosis was of a 
recurrent DFSP with pigmentation and myoid differen-
tiation. At a six-month follow-up appointment, the 
 
Figure 1: A: Contrast-enhanced computed tomography of 
a recurrent swelling in the right arm of a 44-year-old 
woman showing a homogenously-enhancing mass. B: Gross 
photograph of the excised lesion showing a greyish-white 
mass with stretching of the overlying skin.
 
Figure 2: Haematoxylin and eosin stains at (A) x100 
magnification and (B) x200 magnification showing areas 
of myoid differentiation and (C) at x400 magnification 
showing monomorphic spindle cells with interspersed pig- 
mented cells.
 
Figure 3: Immunohistochemical panel at x200 magnification showing (A) diffuse positivity for cluster of differentiation 
(CD)34 and (B) smooth muscle actin expression in areas of myoid differentiation and (C) negativity for CD34.
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The pigmented subtype of DFSP, also known as a 
Bednar tumour or storiform neurofibroma, contains 
varying amounts of melanotic pigment.13 This subtype 
is different from conventional DFSP and has specific 
chromosomal abnormalities.14 However, the origin of 
pigmented DFSP is still unknown. Some researchers 
advocate a neuroectodermal origin due to the presence 
of cells of Schwannian differentiation along with 
dendritic melanocytes, while others believe that such 
tumours arise after trauma, scarring from vaccinations 
or insect and animal bites.15,16 Although several cases 
of DFSP with fibrosarcomatous differentiation are 
available in the literature, the current case appears 
to be the first report of recurrent DFSP with myoid 
differentiation and pigmentation.17–19
Conclusion
Myoid differentiation is a morphological variant of 
DFSP. In the current case, myoid differentiation was 
found around the blood vessels in the tumour, distrib-
uted irregularly without forming a specific stromal 
pattern. It is possible that hyperplastic myofibroblasts 
occur due to a reactive process to proliferating tumour 
cells. However, further studies are needed to enhance 
our understanding of myoid differentiation and its 
clinical prognosis in DFSP cases.
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